Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems

Sunil Shrestha, Januka Khatri, Sujyoti Shakya, Krisha Danekhu, Asmita Priyadarshini Khatiwada, Ranjit Sah, Bhuvan Kc, Vibhu Paudyal, Saval Khanal, Alfonso J. Rodriguez-Morales

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

20 Citas (Scopus)

Resumen

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-2021, has caused enormous damage to health and lives globally. The urgent public health need has led to the development of vaccines against COVID-19 in record-breaking time. The COVID-19 vaccines have been widely rolled out for the masses by many countries following approval for emergency use by the World Health Organization and regulatory agencies in many countries. In addition, several COVID-19 vaccine candidates are undergoing clinical trials. However, myths, fears, rumors, and misconceptions persist, particularly in regard to adverse events. In this commentary, we describe the adverse events associated with COVID-19 vaccines and discuss why it is essential to have a functional adverse event monitoring system in this context.

Idioma originalInglés
Páginas (desde-hasta)376-382
Número de páginas7
PublicaciónDrugs and Therapy Perspectives
Volumen37
N.º8
DOI
EstadoPublicada - ago. 2021
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems'. En conjunto forman una huella única.

Citar esto